Skip to main content
SpringerLink
Log in

Zijn er alternatieven voor hormoonsuppletietherapie bij overgangsklachten?

  • Chapter
Vademecum permanente nascholing huisartsen

  • 71 Accesses

Samenvatting

Overgangsverschijnselen ontstaan door verminderde vorming van oestrogenen. Het betreft vasomotorische klachten, menstruatiestoornissen en urogenitale atrofie.

gynaecoloog, Oosterbeek

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Referenties

  • Kronenberg F. Hot flashes: epidemiology and physiology. Ann N Y Acad Sci 1990; 592: 52-68.

    Google Scholar 

  • Tartaryn IV, Lomax P, Bajorek JG, et al. Postmenopausal hot flushes: a disorder of thermoregulation. Maturitas 1980; 2:101-7.

    Google Scholar 

  • Freedman RR, Krell W. Reduced thermoregulatory null zone in postmenopausal women with hot flashes. Am J Obstet Gynecol 1999; 181: 66-70.

    Google Scholar 

  • Leusden HAIM van. The flush revisited. Eur J Obstet Gynecol Reprod Biol 1994; 57: 137-39.

    Google Scholar 

  • Freedman RR, Dinsay R. Clonidine raises the sweating threshold in symptomatic but not in asymptomatic postmenopausal women. Fertility Sterility 2000; 74: 20-23.

    Google Scholar 

  • Helmerhorst FM, Bijl D. Behandeling van overgangsklachten. Geneesmiddelenbulletin 36: 109-15. (www.geneesmiddelenbulletin.nl)

  • Stearns V, Ullmer L, Lopez JF, et al. Hot flushes. Lancet 2002; 360: 1851-61.

    Google Scholar 

  • Farmacotherapeutisch Kompas 2002. (Loenen AC van, hoofdredacteur). College voor Zorgverzekeringen (CVZ).

    Google Scholar 

  • Pandya KJ, Raubertas RF, Flynn PJ, et al. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Study Center Community Clinical Oncology Program study. Ann Intern Med 2000; 132: 788-93.

    Google Scholar 

  • Hammond MG, Hatley L, Talbert LM. A double blind study to evaluate the effect of methyldopa on menopausal vasomotor flushes. J Clin Endocrinol Metab 1984; 58: 1158-60.

    Google Scholar 

  • Loprinzi CL, Michalak JC, Quella SK, et al. Megestrol acetate for the prevention of hot flushes. N Engl Med 1994; 331: 347-52.

    Google Scholar 

  • Haataja M, Paul R, Gronroos M, et al. Effect of prostaglandin inhibitor and oestrogen on climacterial symptoms and serum free fatty acids. Maturitas 1984; 5: 263-69.

    Google Scholar 

  • Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000; 356: 2059-63.

    Google Scholar 

  • Loprinzi CL, Sloan JA, Perez EA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002; 20: 1578-83.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.bsl.nl

    dr. H.A.I.M. van Leusden

Authors
  1. dr. H.A.I.M. van Leusden
    View author publications

    You can also search for this author in PubMed Google Scholar

Copyright information

© 2006 Bohn Stafleu van Loghum

About this chapter

Cite this chapter

van Leusden, H. (2006). Zijn er alternatieven voor hormoonsuppletietherapie bij overgangsklachten?. In: Vademecum permanente nascholing huisartsen. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-8808-0_590

Download citation

  • DOI: https://doi.org/10.1007/978-90-313-8808-0_590

  • Publisher Name: Bohn Stafleu van Loghum, Houten

  • Print ISBN: 978-90-313-8807-3

  • Online ISBN: 978-90-313-8808-0

  • eBook Packages: Dutch language eBook collection

Publish with us

Policies and ethics

Search

Navigation